Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Colorectal Cancer | Research

Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020

Authors: Zhen Yuan, Shuyuan Wang, Yuqi Wang, Hongzhou Li, Weifeng Gao, Xinyu Liu, Youkui Han, Zhaoce Liu, Qinghuai Zhang, Hong Ma, Junying Wang, Xiaomeng Wei, Xipeng Zhang, Wei Cui, Chunze Zhang

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Purpose

Colorectal cancer (CRC) screening has been implemented in Tianjin, China since 2012. The objective was to estimate the neoplasia detection rate in a high-risk population by age and sex and to investigate the potential factors associated with colorectal neoplasia.

Patients and methods

This study is based on data of the Tianjin CRC screening program from 2012 to 2020. Residents with a positive high-risk factors questionnaire (HRFQ) or a positive faecal immunochemical test (FIT) were identified as high-risk participants and were subsequently recommended for a free colonoscopy.

Results

A total of 4,117,897 eligible participants aged 40–74 years completed both a HRFQ and FIT, and 217,164 (5.3%) of them were identified as high-risk participants. Positive rates of preliminary screening increased with age and were higher in females than in males. For 57,971 participants undertaking colonoscopy, the detection rates of nonadvanced adenoma, advanced adenoma and CRC were 37.8%, 5.7% and 1.6%, respectively. Detection rates of advanced neoplasia increased from the age of 50 and were higher in males. For nonadvanced neoplasia, a strong increase was observed in males from the age of 40 and in females from the age of 50. Male sex had a greater impact on individuals aged 40–49 than on older individuals. Several factors including current smoking, drinking, and higher body mass index (BMI) were significantly associated with the presence of neoplasia, whereas, these associations were mainly restricted to individuals aged above 50 but not those aged 40–49 years.

Conclusions

These findings support that age-specific risk stratification and sex-specific initiating ages for CRC screening should be recommended to improve the accuracy and effectiveness of current screening strategy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profilesa of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91.PubMedCrossRef Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profilesa of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91.PubMedCrossRef
2.
go back to reference Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–7.PubMedCrossRef Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–7.PubMedCrossRef
3.
go back to reference Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–32.PubMedCrossRef Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–32.PubMedCrossRef
4.
go back to reference Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007;56(11):1585–9.PubMedPubMedCentralCrossRef Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007;56(11):1585–9.PubMedPubMedCentralCrossRef
5.
go back to reference Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci. 2015;60(3):762–72.PubMedCrossRef Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci. 2015;60(3):762–72.PubMedCrossRef
7.
go back to reference Zhiqiang F, Jie C, Yuqiang N, et al. Analysis of population-based colorectal cancer screening in Guangzhou, 2011–2015. Cancer Med. 2019;8(5):2496–502.PubMedPubMedCentralCrossRef Zhiqiang F, Jie C, Yuqiang N, et al. Analysis of population-based colorectal cancer screening in Guangzhou, 2011–2015. Cancer Med. 2019;8(5):2496–502.PubMedPubMedCentralCrossRef
8.
go back to reference Liao Y, Li S, Chen C, et al. Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy. Gastroenterol Rep (Oxf). 2018;6(2):132–6.PubMedCrossRef Liao Y, Li S, Chen C, et al. Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy. Gastroenterol Rep (Oxf). 2018;6(2):132–6.PubMedCrossRef
9.
go back to reference Li JB, Qiu ZY, Deng YX, et al. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China. Discov Oncol. 2022;13(1):4.PubMedPubMedCentralCrossRef Li JB, Qiu ZY, Deng YX, et al. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China. Discov Oncol. 2022;13(1):4.PubMedPubMedCentralCrossRef
10.
go back to reference Wu WM, Gu K, Yang YH, et al. Improved risk scoring systems for colorectal cancer screening in Shanghai. China Cancer Med. 2022;11(9):1972–83.PubMedCrossRef Wu WM, Gu K, Yang YH, et al. Improved risk scoring systems for colorectal cancer screening in Shanghai. China Cancer Med. 2022;11(9):1972–83.PubMedCrossRef
11.
go back to reference Wu WM, Wang Y, Jiang HR, et al. Colorectal cancer screening modalities in Chinese population: practice and lessons in Pudong new area of shanghai. China Front Oncol. 2019;9:399.PubMedCrossRef Wu WM, Wang Y, Jiang HR, et al. Colorectal cancer screening modalities in Chinese population: practice and lessons in Pudong new area of shanghai. China Front Oncol. 2019;9:399.PubMedCrossRef
12.
go back to reference Gong Y, Peng P, Bao P, et al. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai. China Oncologist. 2018;23(8):928–35.PubMedCrossRef Gong Y, Peng P, Bao P, et al. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai. China Oncologist. 2018;23(8):928–35.PubMedCrossRef
13.
go back to reference Cai SR, Huang YQ, Zhang SZ, Li QR, Ma XY, Zheng S. Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results. BMC Cancer. 2019;19(1):47.PubMedPubMedCentralCrossRef Cai SR, Huang YQ, Zhang SZ, Li QR, Ma XY, Zheng S. Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results. BMC Cancer. 2019;19(1):47.PubMedPubMedCentralCrossRef
14.
go back to reference Li W, Zhao LZ, Ma DW, et al. Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test. Medicine (Baltimore). 2018;97(18):e0529.PubMedCrossRef Li W, Zhao LZ, Ma DW, et al. Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test. Medicine (Baltimore). 2018;97(18):e0529.PubMedCrossRef
15.
go back to reference Zhao L, Zhang X, Chen Y, Wang Y, Zhang W, Lu W. Does self-reported symptom questionnaire play a role in nonadherence to colonoscopy for risk-increased population in the Tianjin colorectal cancer screening programme? BMC Gastroenterol. 2021;21(1):117.PubMedPubMedCentralCrossRef Zhao L, Zhang X, Chen Y, Wang Y, Zhang W, Lu W. Does self-reported symptom questionnaire play a role in nonadherence to colonoscopy for risk-increased population in the Tianjin colorectal cancer screening programme? BMC Gastroenterol. 2021;21(1):117.PubMedPubMedCentralCrossRef
16.
go back to reference Zheng GM, Choi BC, Yu XR, Zou RB, Shao YW, Ma XY. Mass screening for rectal neoplasm in Jiashan County. China J Clin Epidemiol. 1991;44(12):1379–85.PubMedCrossRef Zheng GM, Choi BC, Yu XR, Zou RB, Shao YW, Ma XY. Mass screening for rectal neoplasm in Jiashan County. China J Clin Epidemiol. 1991;44(12):1379–85.PubMedCrossRef
17.
go back to reference Cai SR, Zhang SZ, Zhu HH, et al. Performance of a colorectal cancer screening protocol in an economically and medically underserved population. Cancer Prev Res (Phila). 2011;4(10):1572–9.PubMedCrossRef Cai SR, Zhang SZ, Zhu HH, et al. Performance of a colorectal cancer screening protocol in an economically and medically underserved population. Cancer Prev Res (Phila). 2011;4(10):1572–9.PubMedCrossRef
18.
go back to reference Wang L, Li HZ, Zhu C, et al. Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013–2018. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(12):2080–6.PubMed Wang L, Li HZ, Zhu C, et al. Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013–2018. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(12):2080–6.PubMed
19.
go back to reference Guo C, Liu Q, Dai M. Colorectal cancer screening: situation and prospect. Zhonghua Yu Fang Yi Xue Za Zhi. 2015;49(5):377–80.PubMed Guo C, Liu Q, Dai M. Colorectal cancer screening: situation and prospect. Zhonghua Yu Fang Yi Xue Za Zhi. 2015;49(5):377–80.PubMed
20.
go back to reference Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol. 2009;15(48):6111–6.PubMedPubMedCentralCrossRef Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol. 2009;15(48):6111–6.PubMedPubMedCentralCrossRef
21.
go back to reference Naber SK, Kuntz KM, Henrikson NB, et al. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer. Gastroenterology. 2018;154(1):105-116.e120.PubMedCrossRef Naber SK, Kuntz KM, Henrikson NB, et al. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer. Gastroenterology. 2018;154(1):105-116.e120.PubMedCrossRef
22.
go back to reference Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for Colorectal Cancer Screening. Gastroenterology. 2020;158(2):418–32.PubMedCrossRef Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for Colorectal Cancer Screening. Gastroenterology. 2020;158(2):418–32.PubMedCrossRef
24.
go back to reference Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244-1260.e1216.PubMedCrossRef Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244-1260.e1216.PubMedCrossRef
25.
go back to reference Nimptsch K, Wu K. Is timing important? The role of diet and lifestyle during early life on colorectal neoplasia. Current Colorectal Cancer Reports. 2018;14(1):1–11.PubMedPubMedCentralCrossRef Nimptsch K, Wu K. Is timing important? The role of diet and lifestyle during early life on colorectal neoplasia. Current Colorectal Cancer Reports. 2018;14(1):1–11.PubMedPubMedCentralCrossRef
26.
27.
go back to reference Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361(9368):1496–501.PubMedCrossRef Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361(9368):1496–501.PubMedCrossRef
28.
go back to reference Ferrari P, Jenab M, Norat T, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007;121(9):2065–72.PubMedCrossRef Ferrari P, Jenab M, Norat T, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007;121(9):2065–72.PubMedCrossRef
29.
go back to reference Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005;97(12):906–16.PubMedCrossRef Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005;97(12):906–16.PubMedCrossRef
30.
go back to reference Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920–31.PubMedCrossRef Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920–31.PubMedCrossRef
31.
go back to reference Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22.PubMedPubMedCentralCrossRef Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22.PubMedPubMedCentralCrossRef
32.
go back to reference Kim NH, Jung YS, Yang HJ, et al. Prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults (20–39 Years Old). Clin Gastroenterol Hepatol. 2019;17(1):115–22.PubMedCrossRef Kim NH, Jung YS, Yang HJ, et al. Prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults (20–39 Years Old). Clin Gastroenterol Hepatol. 2019;17(1):115–22.PubMedCrossRef
33.
go back to reference Low EE, Demb J, Liu L, et al. Risk factors for early-onset colorectal cancer. Gastroenterology. 2020;159(2):492-501.e497.PubMedCrossRef Low EE, Demb J, Liu L, et al. Risk factors for early-onset colorectal cancer. Gastroenterology. 2020;159(2):492-501.e497.PubMedCrossRef
34.
go back to reference Jung YS, Ryu S, Chang Y, et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointest Endosc. 2015;81(3):637-645.e637.PubMedCrossRef Jung YS, Ryu S, Chang Y, et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointest Endosc. 2015;81(3):637-645.e637.PubMedCrossRef
35.
go back to reference Hong SN, Kim JH, Choe WH, et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc. 2010;72(3):480–9.PubMedCrossRef Hong SN, Kim JH, Choe WH, et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc. 2010;72(3):480–9.PubMedCrossRef
36.
go back to reference Agazzi S, Lenti MV, Klersy C, et al. Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy. Eur J Intern Med. 2021;87:36–43.PubMedCrossRef Agazzi S, Lenti MV, Klersy C, et al. Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy. Eur J Intern Med. 2021;87:36–43.PubMedCrossRef
37.
go back to reference Zhang M, Zhao L, Zhang Y, et al. Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study. Front Oncol. 2022;12:893183.PubMedPubMedCentralCrossRef Zhang M, Zhao L, Zhang Y, et al. Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study. Front Oncol. 2022;12:893183.PubMedPubMedCentralCrossRef
38.
go back to reference Lin G, Feng Z, Liu H, Li Y, Nie Y, Liang Y, Li K. Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China. Sci Rep. 2019;9(1):10424.PubMedPubMedCentralCrossRef Lin G, Feng Z, Liu H, Li Y, Nie Y, Liang Y, Li K. Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China. Sci Rep. 2019;9(1):10424.PubMedPubMedCentralCrossRef
39.
go back to reference Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103–10.PubMedPubMedCentralCrossRef Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103–10.PubMedPubMedCentralCrossRef
40.
go back to reference Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol. 2009;15(48):6111–6.PubMedPubMedCentralCrossRef Meng W, Cai SR, Zhou L, Dong Q, Zheng S, Zhang SZ. Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol. 2009;15(48):6111–6.PubMedPubMedCentralCrossRef
41.
go back to reference Wong MC, Lam TY, Tsoi KK, Hirai HW, Chan VC, Ching JY, Chan FK, Sung JJ. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63(7):1130–6.PubMedCrossRef Wong MC, Lam TY, Tsoi KK, Hirai HW, Chan VC, Ching JY, Chan FK, Sung JJ. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63(7):1130–6.PubMedCrossRef
42.
go back to reference Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. 2019;68(10):1820–6.PubMedCrossRef Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. 2019;68(10):1820–6.PubMedCrossRef
43.
go back to reference Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–85.PubMedCrossRef Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–85.PubMedCrossRef
44.
go back to reference Troeung L, Sodhi-Berry N, Martini A, et al. Increasing incidence of colorectal cancer in adolescents and young adults aged 15–39 years in Western Australia 1982–2007: examination of colonoscopy history. Front Public Health. 2017;5:179.PubMedPubMedCentralCrossRef Troeung L, Sodhi-Berry N, Martini A, et al. Increasing incidence of colorectal cancer in adolescents and young adults aged 15–39 years in Western Australia 1982–2007: examination of colonoscopy history. Front Public Health. 2017;5:179.PubMedPubMedCentralCrossRef
45.
go back to reference Wong MCS, Huang J, Lok V, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955-966.e961.PubMedCrossRef Wong MCS, Huang J, Lok V, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955-966.e961.PubMedCrossRef
46.
go back to reference Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2021;325(19):1965–77.PubMedCrossRef Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2021;325(19):1965–77.PubMedCrossRef
47.
go back to reference Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134(2):388–95.PubMedCrossRef Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134(2):388–95.PubMedCrossRef
48.
go back to reference Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290(22):2959–67.PubMedCrossRef Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290(22):2959–67.PubMedCrossRef
49.
go back to reference Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol. 2008;167(9):1050–8.PubMedCrossRef Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol. 2008;167(9):1050–8.PubMedCrossRef
50.
go back to reference Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol. 2009;7(6):682-688.e681-685.PubMedCrossRef Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol. 2009;7(6):682-688.e681-685.PubMedCrossRef
51.
52.
go back to reference Connell LC, Mota JM, Braghiroli MI, Hoff PM. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol. 2017;18(4):23.PubMedCrossRef Connell LC, Mota JM, Braghiroli MI, Hoff PM. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol. 2017;18(4):23.PubMedCrossRef
53.
go back to reference Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8(4):288–98.PubMedCrossRef Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8(4):288–98.PubMedCrossRef
55.
go back to reference Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology. 2019;157(1):137–48.PubMedCrossRef Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology. 2019;157(1):137–48.PubMedCrossRef
Metadata
Title
Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020
Authors
Zhen Yuan
Shuyuan Wang
Yuqi Wang
Hongzhou Li
Weifeng Gao
Xinyu Liu
Youkui Han
Zhaoce Liu
Qinghuai Zhang
Hong Ma
Junying Wang
Xiaomeng Wei
Xipeng Zhang
Wei Cui
Chunze Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-03060-3

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine